-+ 0.00%
-+ 0.00%
-+ 0.00%

Scotiabank Maintains Sector Outperform on Agios Pharmaceuticals, Lowers Price Target to $71

Benzinga·05/02/2025 14:16:09
Listen to the news
Scotiabank analyst Greg Harrison maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sector Outperform and lowers the price target from $74 to $71.